DIQ Morning Briefing - Apr 20th, 2026

DIQ Morning Briefing - Apr 20th, 2026

This anticoagulent reversal agent is off the market. Now what?

DIQ Morning Briefing | View online

Happy Monday, everyone!

Andexxa, a popular anticoagulant reversal agent for two drugs, has been discontinued. If patients taking these drugs risk life-threatening bleeding as a side effect, why isn't there a current "backup" reversal agent to replace Andexxa? How can dental professionals manage patients with this heightened risk who require oral surgery or have dental trauma?

Check out the latest Medical History Mysteries video to learn more.

Sponsored

Smarter Dental Marketing Starts with CallRail

Gain valuable insights from every patient call and optimize your marketing. With AI in every plan, calls are automatically tracked, recorded, transcribed, and analyzed. No add-ons. No upgrades. CallRail offers deeper insights, higher value, and more for your money. Plus, the first 14 days are completely free! It’s time to book more appointments and increase your return on investment.

Try it now, no card required

Connect With Us

This email is being sent to @{email name}@.

Please add news.dentistryiq.com to your address book or safe sender list to receive our emails in your inbox.

Unsubscribe | Manage Newsletter Subscriptions | Forward to a Friend | Customer Service Center | Read Privacy Policy

If this email was forwarded to you and you are interested in subscribing, please click here to sign-up.

If you have trouble with any of these methods, you can reach us toll-free at 800-547-7377.

Dentistry IQ
EndeavorB2B
30 Burton Hills Blvd., Suite 185
Nashville, TN 37215